Biological
IM19 CAR-T
IM19 CAR-T is a biological therapy with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
3
75%
Ph not_applicable
1
25%
Phase Distribution
3
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
3(75.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(1)
Other(3)
Detailed Status
unknown3
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 13 (75.0%)
N/A1 (25.0%)
Trials by Status
completed125%
unknown375%
Recent Activity
0 active trials
Showing 4 of 4
unknownnot_applicable
Efficacy and Safety Evaluation of IM19 CAR-T Cell Therapy for MRD+ After Transplantation
NCT04336501
completedphase_1
Safety and Efficacy Evaluation of IM19 CAR-T Cells (IM19CAR-T)
NCT03173417
unknownphase_1
Safety and Efficacy Evaluation of IM19 CAR-T Cells
NCT03142646
unknownphase_1
Safety and Efficacy Evaluation of IM19 Cells
NCT03344705
Clinical Trials (4)
Showing 4 of 4 trials
NCT04336501Not Applicable
Efficacy and Safety Evaluation of IM19 CAR-T Cell Therapy for MRD+ After Transplantation
NCT03173417Phase 1
Safety and Efficacy Evaluation of IM19 CAR-T Cells (IM19CAR-T)
NCT03142646Phase 1
Safety and Efficacy Evaluation of IM19 CAR-T Cells
NCT03344705Phase 1
Safety and Efficacy Evaluation of IM19 Cells
All 4 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 4